Schedule 13D ownership disclosure

HOOKIPA PHARMA INC

Common Stock, par value $0.0001 per share · CUSIP: 43906K209

Event date: 2025-02-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sofinnova Capital VI FCPRReported CIK 0001441261

    Shares: 314,259.00 · Class: 2.6%

  • Sofinnova Partners SASReported CIK 0001574139

    Shares: 314,259.00 · Class: 2.6%

  • Antoine PapiernikReported CIK 0001768408

    Shares: 314,259.00 · Class: 2.6%

  • Henrijette Richter

    Shares: 314,259.00 · Class: 2.6%

  • Maina BhamanReported CIK 0001901013

    Shares: 314,259.00 · Class: 2.6%

  • Graziano SeghezziReported CIK 0001573749

    Shares: 314,259.00 · Class: 2.6%

  • Anta Gkelou

    Shares: 314,259.00 · Class: 2.6%

  • Karl Naegler

    Shares: 314,259.00 · Class: 2.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014167
Form type
SCHEDULE 13D/A
Filer
HOOKIPA Pharma Inc.
CIK
CIK 1760542
Filed
Feb 14, 2025
Reporting period
Feb 14, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub